Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 34.00 is 111% above its 5-year average of 16.11, around the middle of its 5-year range (0.94–67.69).
As of the fiscal period ended Tuesday, June 30, 2026. 34.65% below its 12-month average of 52.03.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 34.00.
CURRENT RATIO
34.00
CURRENT RATIO AVG TTM
52.03
CURRENT RATIO AVG 3Y
26.19
CURRENT RATIO AVG 5Y
16.11
CURRENT RATIO AVG 10Y
11.27
CURRENT RATIO AVG 15Y
13.24
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-34.65%
CURRENT VS 3Y AVG
+29.81%
CURRENT VS 5Y AVG
+111.08%
CURRENT VS 10Y AVG
+201.71%
CURRENT VS 15Y AVG
+156.84%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
+845.70%
vs the sector median at left
Benitec Biopharma Inc.
Market Cap
$304.21M
Current Ratio
34.00
TTM Avg
52.03
3Y Avg
26.19
5Y Avg
16.11
Market Cap
$309.71M
Current Ratio
13.28
TTM Avg
4.54
3Y Avg
4.54
5Y Avg
4.54
Market Cap
$296.59M
Current Ratio
4.70
TTM Avg
5.10
3Y Avg
7.75
5Y Avg
8.34
Market Cap
$288.33M
Current Ratio
45.02
TTM Avg
28.56
3Y Avg
20.10
5Y Avg
23.41
Market Cap
$288.21M
Current Ratio
6.63
TTM Avg
6.50
3Y Avg
6.00
5Y Avg
4.95
Market Cap
$287.88M
Current Ratio
4.69
TTM Avg
11.27
3Y Avg
11.27
5Y Avg
11.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $304.21M | 34.00 | 52.03 | 26.19 | 16.11 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.71M | 13.28 | 4.54 | 4.54 | 4.54 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $296.59M | 4.70 | 5.10 | 7.75 | 8.34 |
| C4 Therapeutics, Inc. (CCCC)vs › | $319.54M | 5.45 | 6.76 | 6.58 | 6.90 |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.33M | 45.02 | 28.56 | 20.10 | 23.41 |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.21M | 6.63 | 6.50 | 6.00 | 4.95 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $287.88M | 4.69 | 11.27 | 11.27 | 11.27 |
| Avita Medical Inc. (RCEL)vs › | $321.44M | 0.41 | 1.70 | 4.87 | 7.66 |
| Standard BioTools Inc. (LAB)vs › | $286.75M | 9.10 | 4.95 | 4.04 | 3.29 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | 19.48 | 1.73 | 4.11 | 4.35 |
Current Ratio
34.00
Quick Ratio
34.00
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 34.00 |
| 2026-03-31 | 56.82 |
| 2025-12-31 | 67.69 |
| 2025-09-30 | 46.95 |
| 2025-06-30 | 54.67 |
| 2025-03-31 | 14.80 |
| 2024-12-31 | 25.48 |
| 2024-09-30 | 15.01 |
| 2024-06-30 | 10.49 |
| 2024-03-31 | 4.18 |
| 2023-12-31 | 3.62 |
| 2023-09-30 | 5.83 |
| 2023-06-30 | 0.94 |
| 2023-03-31 | 2.35 |
| 2022-12-31 | 4.41 |
| 2022-09-30 | 5.67 |
| 2022-06-30 | 1.90 |
| 2022-03-31 | 4.63 |
| 2021-12-31 | 5.11 |
| 2021-09-30 | 10.23 |
| 2021-06-30 | 15.05 |
| 2021-03-31 | 5.08 |
| 2020-12-31 | 18.46 |
| 2020-09-30 | 7.91 |
| 2020-06-30 | 9.51 |
| 2020-03-31 | 12.97 |
| 2019-12-31 | 20.30 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 10.17 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 13.96 |
| 2018-09-30 | 13.96 |
| 2018-06-30 | 8.20 |
| 2018-03-31 | 8.63 |
| 2017-12-31 | 9.64 |
| 2017-09-30 | 11.79 |
| 2017-06-30 | 19.70 |
| 2017-03-31 | 21.63 |
| 2016-12-31 | 14.15 |
| 2016-09-30 | 28.44 |
| 2016-06-30 | 18.73 |
| 2016-03-31 | 15.69 |
| 2015-12-31 | 27.72 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 15.26 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 41.62 |
| 2014-09-30 | 41.62 |
| 2014-06-30 | 15.26 |
| 2014-03-31 | 36.07 |
| 2013-12-31 | 19.93 |
| 2013-09-30 | 19.93 |
| 2013-06-30 | 33.37 |
| 2013-03-31 | 1.55 |
| 2012-12-31 | 1.68 |
| 2012-09-30 | 1.68 |
